do people gain weight back after stopping glp 1 Many Patients Maintain Loss a Year Semaglutide and Liraglutide In recent years, GLP-1 medications

Blocking components in sample dilution buffer can decrease or remove the interference

In December 2024, that share had only reached 14.9%

Second, as a sensitivity analysis to address concerns regarding treatment indication heterogeneity, we repeated the primary analysis in a restricted cohort consisting of patients with T2D only

A provider that exits the market leaves you scrambling for continuity of care

Additional Phase 3 trials are still underway, including TRIUMPH-2 (evaluating retatrutide in adults with obesity and type 2 diabetes) and TRIUMPH-3 (evaluating cardiovascular outcomes), with results expected later in 2026

For our full lineup ranked by price, see our guide to the cheapest tirzepatide providers